HOME >> MEDICINE >> NEWS
Gene expression test reveals ER and HER-2 status of breast tumors

HOUSTON - Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online.

Researchers developed and validated a new genomic microarray test that identifies whether a tumor's growth is fueled by the female hormone estrogen and the role of a growth factor receptor known as HER-2 that makes a tumor vulnerable to a specific drug. The status of these factors is now determined by pathology tests.

"This is one important step towards personalized diagnosis and treatment planning based on an integrated genomic test of an individual tumor," said senior author W. Fraser Symmans, M.D., associate professor in the M. D. Anderson Department of Pathology. The Lancet Oncology paper results are the latest in an effort by the research team to develop a single test to quickly and efficiently determine the characteristics and vulnerabilities of a patient's breast cancer and ultimately to guide treatment.

About 70 percent of breast cancers are estrogen-receptor positive and another 15 to 25 percent are human epidermal growth factor receptor-2 (HER-2) positive. Each receptor status requires different types of treatment.

The gene expression tests were 90 percent accurate for both receptors, which makes them comparable to, if not better than, existing pathology tests.

"This moves us closer to developing an integrated single genomic test that could estimate the risk of cancer relapse after surgery, determine the ER and HER2 receptor status, and also gauge the sensitivity of the tumor to hormone therapy and chemotherapy," says Lajos Pusztai, M.D., Ph.D., associate professor in the M. D. Anderson Department of Breast Medical Oncology, and team leader with Symmans.

ER-positive tumors are treated with estrogen-suppressing drugs such
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
14-Feb-2007


Page: 1 2

Related medicine news :

1. XDx presents success with AlloMap molecular expression testing to international transplant community
2. Chronic alcohol exposure can affect brain protein expression
3. Core needle biopsy gives an accurate picture of gene expression in whole tumor
4. Different gene-expression predictors of breast cancer agree, UNC study shows
5. Gene expression in labor; and more -- press release from PLoS Medicine
6. Gene expression pattern predicts multiple drug resistance, treatment failure in pediatric leukemia
7. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
8. Study reveals gaps in vaccine financing for underinsured children
9. UT study reveals inaccuracies in cardiac PET-CT imaging, finds fixes
10. Cars imaging reveals clues to myelin damage
11. Detecting cold, feeling pain: Study reveals why menthol feels fresh

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene expression test reveals and HER status breast tumors

(Date:5/21/2013)... May 21, 2013 Medical Ministry International ... prestigious 2013 Top-Rated Award by GreatNonprofits , the leading ... excited to be named a Top-Rated 2013 Nonprofit,” says Samuel ... dedication of our over 3000 Volunteers and Staff serving in ... as it came from those that have seen our work ...
(Date:5/21/2013)... New York, New York (PRWEB) May 21, 2013 ... protecting the rights of victims injured by defective medical devices, ... attorney in the case of the Estate of Fred E. ... Kitsap County (Port Orchard). A May 21, 2013, Bloomberg ... Intuitive Surgical had acted like a “car dealership” in how ...
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 ContinuCare ... the Texas Department of Aging and Disability Services. After ... and employee interviews, ContinuCare Home Health was found ... The review is part of the Department of Aging ... of aging and disability services, supports and opportunities ...
(Date:5/21/2013)... HealthSmart continues to grow through strategic ... required the hiring of new talent in several areas, ... announce that Dawn Powell has joined the organization effective ... of Account Management in the Central Region and is ... With extensive client management, employee benefits, and product development ...
(Date:5/21/2013)... stent, which is a novel stent platform eluting ... the Xience Prime everolimus-eluting stent for the primary ... nine months in the results of an imaging ... BIOFLOW-II substudy used intravascular ultrasound (IVUS) and optical ... and stent apposition at nine months after treating ...
Breaking Medicine News(10 mins):Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2
(Date:5/21/2013)... May 21, 2013 Kepner-Tregoe (KT), the ... that 13-year veteran Chris Geraghty ... experience includes more than 20 years serving the ... manufacturing organizations. He succeeds Ray Baxter ... Kepner-Tregoe,s Chairman of the Board and CEO. ...
(Date:5/21/2013)... 21, 2013  Armada Health Care (Armada) is ... Armada corporate website ( www.armadahealthcare.com ).  This new ... and first-to-market services and its position as the ... specialty pharmacy industry. The updated website ... business model in delivering an extensive portfolio of ...
(Date:5/21/2013)... 2013 Hurel Corporation ("Hurel"), a world-leading provider ... platforms, today announced the appointment of James ... Board of Directors. Dr. MacDonald is the former Executive ... Institute ("SPRI"), which was the pharmaceutical development arm of ... Co. in 2009. Over a career that ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
Cached News: